BN Business News
Add your company to Business Communicator →

Business · 14/09/2009Updated: 10/17/2026 · 1 min read

FDA Announces Draft Guidance for Surgical Ablation Devices for Atrial Fibrillation Treatment

Summary

The FDA has released a draft guidance outlining proposed clinical trial designs for surgical ablation devices aimed at treating atrial fibrillation, a condition affecting the heart's rhythm.

Original source language: Federal Register — Food and Drug AdministrationOpen original release →

Explore insights

Business insights →